Evidence map›Paper›PMID 34587940›Full record

ArticleBMC musculoskeletal disorders2021

Hybrid Oxford unicompartmental knee arthroplasty has lower residual cement extrusion than cemented arthroplasty in treating end-stage unicompartmental knee osteoarthritis.

Guangzhong Yang, Xufeng Jiao, Qianli Li, Zheng Li, Shuai An, Mingli Feng, Guanghan Gao, Jiang Huang, Guanglei Cao

Open access · goldAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Guangzhong Yang *Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100032, China.
Xufeng Jiao *Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100032, China.
Qianli LiXuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100032, China.
Zheng LiXuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100032, China.
Shuai AnXuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100032, China.
Mingli FengXuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100032, China.
Guanghan GaoXuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100032, China.
Jiang HuangXuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100032, China.
Guanglei CaoXuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100032, China. gregary111@163.com.
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHybrid Oxford unicompartmental knee arthroplasty (OUKA) consists of cementless femoral prostheses and cemented tibial prostheses. Although a hybrid OUKA has been used in clinical practice, the clinical outcome has not been reported. The purpose of this study was to compare the short-term clinical outcomes and rate of residual bone cement extrusion between hybrid and cemented prostheses and analyse the possible reasons for differences between outcomes.

methodsA total of 128 knees (118 patients) with end-stage osteoarthritis were included in this study, of which underwent consecutive operations using unicondylar Oxford phase 3 implants from July 2017 and September 2019 in our centre. Follow-up was performed at 6 weeks, 3 and 6 months, 1 year and every year after operation, and complications and changes in the Oxford knee score (OKS) were recorded. The OKS of the two groups was analysed by the generalized estimating equation approach. Prosthesis-based standard fluoroscopy was performed in a timely manner after each operation, and the rate of residual cement extrusion of the two groups was estimated using T-tests and a multivariate regression analysis.

resultsExcluding the cases that lost follow-up, a total of 120 knees (65 in hybrid group and 55 in cemented group) were included in the analysis. There was no statistically significant difference in patient characteristics between the two groups (p > 0.05). The average follow-up time was 23.4 months (and ranged from 12 to 38 months). As of the last follow-up, there were no complications, such as dislocation, fracture, prosthesis loosening and subsidence, but one patient in the cemented group experienced symptoms caused by residual loose cement. Postoperative OKS in both groups improved significantly (p < 0.001). There was no significant difference in the OKS at any point during the follow-up or in the improvement of the OKS between the two groups (p > 0.05). Residual cement was mainly extruded behind the tibial prosthesis. The rate of hybrid periprosthetic residual cement extrusion was significantly lower in the hybrid group than in the cemented group, and the difference was statistically significant (OR = 3.38; p = 0.014).

conclusionsHybrid OUKA is as effective as cemented OUKA in the short term after operation and can significantly reduce the residual cement extrusion rate around the tibial prosthesis.

Indexed as

Arthroplasty, Replacement, KneeKnee ProsthesisOsteoarthritis, KneeBone CementsHumansKnee JointProsthesis DesignProsthesis FailureTreatment OutcomeBone CementsCement extrusionHybridOUKA outcomeUnicompartmental knee arthroplasty

Identifiers

PMID34587940
PMCPMC8479987
OpenAlexW3202937670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.